Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Dana-Farber Cancer Institute
Boston, MA 02215- Is this information wrong?
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2019 - 2022
- Massachusetts General HospitalResidency, Internal Medicine, 2016 - 2019
- Stanford University School of MedicineClass of 2016
Certifications & Licensure
- MA State Medical License 2016 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients.Julia Keating, Donna S Neuberg, R Coleman Lindsley, Shai Shimony, Jacqueline S Garcia, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Daniel J DeAngelo, Richard M Stone> ;Leukemia. 2024 Mar 27
- 1 citationsHypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML.Shai Shimony, Jan Philipp Bewersdorf, Rory M Shallis, Yiwen Liu, Eva J Schaefer, Amer M Zeidan, Aaron D Goldberg, Eytan M Stein, Guido Marcucci, R Coleman Lindsley, Ev...> ;Leukemia. 2024 Apr 1
- Tri-ing to decipher trisomy AML.Shimony, S., Chen, E.> ;British Journal of Haematology. 2024 Mar 1
- Join now to see all
Hospital Affiliations
- Massachusetts General HospitalBoston, Massachusetts
- Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: